The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02782338|
Recruitment Status : Unknown
Verified May 2016 by Lili karmona, Wolfson Medical Center.
Recruitment status was: Not yet recruiting
First Posted : May 25, 2016
Last Update Posted : June 1, 2016
|Condition or disease||Intervention/treatment|
|Blood Coagulation Disorders||Drug: Voltaren ophtha 0.1%|
Objective: To examine the effect of topical Voltaren-Ophtha 0.1% eye drops after cataract surgery on INR levels ( international normalized ratio) in patients taking warfarin.
Methods: A prospective study. The study population will include approximately 100 patients, taking warfarin and that are candidates for cataract surgery. These patients will continue their warfarin therapy as usual and at the same dose, before and after the operation.
INR levels (international normalized ratio) will be checked once a week while taking Voltaren eye drops as is customary after cataract surgery.
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||The Effect of Voltaren-ophtha 0.1% (Diclofenac Sodium 0.1%) Eye Drops After Cataract Surgery on INR Levels (International Normalized Ratio) in Patients Taking Warfarin|
|Study Start Date :||May 2016|
|Estimated Primary Completion Date :||May 2017|
|Estimated Study Completion Date :||December 2017|
- Drug: Voltaren ophtha 0.1%
All study patients will be treated with Voltaren ophtha 0.1% after cataract surgeryOther Name: voltaren drops
- INR levels (international normalized ratio) - change is being assessed [ Time Frame: 1 week, 2 weeks, 3 weeks and 4 weeks after taking Voltaren Optha 0.1% ]change is being assessed